TEMPOL Increases uPAR in Prostate Cancer Cells
Author Information
Author(s): Danielle Lejeune, Mohammad Hasanuzzaman, Amanda Pitcock, Joseph Francis, Inder Sehgal
Primary Institution: LSU Department of Comparative Biomedical Sciences, Louisiana State University
Hypothesis
Does the superoxide scavenger TEMPOL affect the expression of the urokinase receptor (uPAR) in human prostate cancer cells?
Conclusion
TEMPOL treatment increases uPAR protein expression in prostate cancer cells through a post-transcriptional mechanism.
Supporting Evidence
- TEMPOL reduced superoxide levels by 75% in prostate cancer cells.
- uPAR protein expression peaked between 48 and 72 hours after TEMPOL treatment.
- The increase in uPAR protein was not matched by a significant increase in uPAR transcript levels.
Takeaway
When scientists added a special chemical called TEMPOL to prostate cancer cells, it made a protein called uPAR increase, which helps the cancer cells move and grow.
Methodology
PC-3M human prostate cancer cells were treated with TEMPOL, and uPAR expression was measured using immunoblotting and real-time PCR.
Limitations
The study does not explore the long-term effects of TEMPOL on uPAR expression or its potential rebound effects after TEMPOL removal.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website